GILD
Gilead Sciences Inc.Stock · HealthcareNasdaq-100 0.7% · Nasdaq Composite 0.4% · S&P 500 0.2% · Russell 1000 0.2% · US Stock Market 0.2% · Russell 3000 0.2% · MSCI World 0.2% · S&P 500 Equal Weight 0.2% · MSCI ACWI 0.2%$143.72-0.75%
as of market close, Sep 11, 2026
☾ AH — —
GILD — Gilead Sciences Inc. price, chart and key statistics
Technical analysis2
Overlay lines0
Addendum charts0
VolumeDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDD
60.070.080.090.0100.0110.0120.0130.0140.0150.00100.0M$143.72—20162019202120242026
2026-09-11
Price$143.72
MA20$134.71
MA50$128.47
Vol31.5M
Key stats
Price data
- Price
- $143.72
- Change YTD
- +18.53%
- Next earnings
- Oct 29, 2026
- Market cap
- 178.2B
- Enterprise value
- 201.8B
- Shares outstanding
- 1.2B
- 52W low
- $108.46
- 52W high
- $157.29
- From 52W high
- -8.63%
- From 52W low
- +32.51%
- 52W range
- 72%
- Beta
- 0.32
Volume
- Rel volume
- 0.69×
- 30D volume
- 6M
- 30D $ vol
- 851.2M
Fundamentals
- Sales (ttm)
- 30.5B
- Sales/share
- $24.56
- EPS (ttm)
- -$2.59
- FCF (ttm)
- 12.9B
- FCF/share
- $10.44
- Book value/share
- $9.54
- Net margin
- -10.64%
- ROE
- -27.39%
- ROA
- -6.56%
- Debt / equity
- 2.01×
- Current ratio
- 1.27
Growth (CAGR, ttm) · 10Y
- Sales
- +5.53%+3.61%+2.72%-0.61%
- FCF
- +38.18%+13.18%+8.85%-3.34%
- Shares
- -0.07%-0.16%-0.22%-0.62%
Per-share growth (CAGR, ttm) · 10Y
- Sales/share
- +5.60%+3.78%+2.94%+0.01%
- FCF/share
- +38.27%+13.37%+9.09%-2.73%
- Book value/share
- -39.85%-17.48%-9.50%-2.08%
- Dividend/share
- +3.21%+2.85%+2.98%+6.23%
- Price
- +21.96%+23.10%+15.14%+6.29%
- Total return
- +25.14%+27.21%+19.42%+10.12%
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- P/E (ttm)
- -55.5×
- P/OI (ttm)
- 15.1×
- Fwd P/E
- 14.8×
- P/S (ttm)
- 5.9×
- P/B (mrq)
- 15.1×
- P/FCF (ttm)
- 13.8×
- EV/EBITDA (fy)
- 736.5×
- EV/Sales (ttm)
- 6.6×
- FCF yield (ttm)
- 7.26%
- Dividend yield (fwd)
- 2.24%
- Dividend/share (fwd)
- $3.22
- Buyback yield (realized, 1y)
- 0.07%
- Shareholder yield (realized, 1y)
- 3.03%
- Buyback yield (cash, ttm)
- 0.64%
- Shareholder yield (cash, ttm)
- 2.92%
Vs own 10Y history
- P/E
- 35th
- P/OI
- 63rd
- P/S
- 98th
- P/B
- 99th
- P/FCF
- 87th
Bar = where today’s multiple sits in GILD’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).
Performance · price return · windows as of 2026-09-11
1D
-0.75%
5D
-4.96%
1M
+5.78%
3M
+14.93%
YTD
+18.53%
1Y
+27.95%
5Y
+138.45%
Financial statements
Open full GILD financials →Loading financial statements…
Related Healthcare
| Ticker | Name | 1M | 1D |
|---|---|---|---|
| LLY | Eli Lilly and Company | -8.44% | -0.65% |
| JNJ | Johnson & Johnson | +2.31% | -0.29% |
| ABBV | AbbVie Inc. | +3.36% | +0.83% |
| MRK | Merck & Co. Inc. | +8.28% | -0.54% |
| UNH | UnitedHealth Group Incorporated Common Stock (DE) | -6.53% | -2.37% |
| TMO | Thermo Fisher Scientific Inc. | +1.13% | +1.10% |
| AMGN | Amgen Inc. | -8.80% | -1.34% |
| ABT | Abbott Laboratories | -8.08% | -1.36% |
Gilead Sciences Inc. (GILD) trades at $143.72 with a live price and an interactive chart covering 34+ years of daily price history, plus key valuation metrics. ChartRow also publishes GILD’s financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full GILD financial statements →
